In this paper, we propose a hypothesis that HMGCR stimulates an increase in oxidized sterol toxicity through lipid disorders and inflammatory responses, leading to neuronal damage in the brain, which in turn serves as a novel target for the treatment of AD. Here, HMGCR is linked to Alzheimer disease.